Biologic Therapy Administration
Evidence-based standards for safe administration of biologic therapies including colony-stimulating factors, monoclonal antibodies, immunoglobulins, and gene therapies. Covers patient assessment, care setting selection, biosimilar considerations, REMS compliance, subcutaneous immunoglobulin administration, and adverse reaction management.